To include your compound in the COVID-19 Resource Center, submit it here.

SciClone expands China ops with NovaMed buy

SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) acquired Chinese specialty pharma NovaMed Pharmaceuticals Inc. (Shanghai, China)

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE